Secondary outcomes
EVENTS
We will examine three medication outcomes measured at the level of the participant: discontinuation, sustained discontinuation, and dose reduction of any target medication and of each target medication (Fig. We will also investigate plans to taper medications from the provider and participant perspective. We will capture the providers’ perspective from actions documented in the signetur field. We will display summary statistics indicating whether a taper was documented in the signetur field for each target medication over 6 months following the medication-specific brochure mailing date, and the mean time from brochure mailing date to documented taper plan. To capture the participants’ perspective on possible tapering, we will use information from the returned postcards. We will present summary statistics indicating the number and proportion of response types tabulated by brochure medication class.For safety outcomes, we will provide the proportion of participants with a safety outcome by group, given that these are likely to be rare events.